Union for International Cancer Control (UICC) is a membership organization that exists to help the global health community accelerate the fight against cancer. Founded in 1933 and based in Geneva, UICC’s growing membership of over 800 organizations across 155 countries, features the world’s major cancer societies, ministries of health, research institutes and patient groups. Together with its members, key partners, the World Health Organization, World Economic Forum and others, UICC is tackling the growing cancer crisis on a global scale.
The Global Coalition for Adaptive Research (GCAR) is an international partnership comprised of some of the world’s foremost clinical, translational, and basic science investigators. Through this collaboration and open exchange of ideas, the ultimate beneficiary—the patient—is supported in the fight against rare and deadly diseases.
National Foundation for Cancer Research (NFCR) is synthetically in alliance with organization of AFCR, located in Maryland, USA. Together, NFCR and AFCR are committed to fighting cancer through research in prevention, earlier diagnostic techniques, more effective treatments and ultimately, achieving one of medicine’s greatest goals: curing cancer. We do this by supporting and fostering innovative, collaborative research programs that work with the best ideas of the best minds across Asia and around the world. Research for a Cure is the key to saving lives.
HKBIO is a charitable organization established in September 2009. Founded by pioneering scientists with extensive life science backgrounds and multi-cultural experience in R&D, engineering and business, HKBIO promotes best practice, raises awareness across the biotechnology industry while providing added value benefits to its members, whether they are students, researchers, entrepreneurs, industry bodies, public or private sector representatives
Hugill & Ip Solicitors is an independent law firm providing bespoke legal advice and exceptional client service to individuals, families, entrepreneurs and businesses, in Hong Kong and internationally. Hugill & Ip provides high quality legal services with integrity, professionalism and respect for clients and the community.
The University of Hong Kong, founded in 1911, is the oldest tertiary institution in Hong Kong. It was granted a shield and a motto by the College of Arms in 1913, and throughout its history the University’s visual identity has been firmly based on their display, often coupled the University’s name. No other university in Hong Kong possesses a coat of arms. This is a distinction that resonates outside Hong Kong, particularly in the United Kingdom, other Commonwealth jurisdictions, and the United States. It is also a reminder of the University’s antiquity, and a most dignified and effective corporate identity.
The Chinese University of Hong Kong is a comprehensive research-led university in Hong Kong delivering high-quality education on both undergraduate and postgraduate levels and serving the community with its cutting-edge research capability.
Tianjin Medical University Cancer Institute and Hospital (TMUCIH) is the birthplace of Oncology in China. It has a history of more than a hundred years and has become one of the most famous modernized cancer hospitals worldwide. It is also one of the largest bases for cancer prevention, treatment, training and research in China.
The CG-CM is a global, non-profit, non-discriminatory and non-political organization, with a mission of advancing the field of Chinese herbal medicine to benefit human kind through joint efforts of the academic institutions, industries and regulatory agencies around the world.
The Chinese Academy of Medical Sciences (CAMS) is the most important medical institution in China and is directly under the leadership of the Ministry of Health. The CAMS was created in 1956 by the Chinese government and was merged with Peking Union Medical College (PUMC) in Beijing. The mission of CAMS is to encourage high-quality research in biomedical science with the aim of improving people’s health and reducing the death rate, to offer the best clinical diagnoses and treatments for severe and rare diseases, to promote the transition of research to clinical applications, and to train first-rate medical professionals for research, clinical applications, and educatio